Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 81-90 of 101 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatmentAdomako, A.; Calvo, V.; Biran, N.; Osman, K.; Chari, A.; Paton, J.; Paton, A.; Moore, K.; Schewe, D.; Aguirre-Ghiso, J.
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2015Trajectory of post-traumatic stress following traumatic injury: 6-year follow-upBryant, R.; Nickerson, A.; Creamer, M.; O'Donnell, M.; Forbes, D.; Galatzer-Levy, I.; McFarlane, A.; Silove, D.
2015Community cardiovascular disease risk from cross-sectional general practice clinical data: a spatial analysisBagheri, N.; Gilmour, B.; McRae, I.; Konings, P.; Dawda, P.; Del Fante, P.; van Weel, C.
2015Aspirin, ibuprofen, and the risk of colorectal cancer in Lynch SyndromeAit Ouakrim, D.; Dashti, S.; Chau, R.; Buchanan, D.; Clendenning, M.; Rosty, C.; Winship, I.; Young, J.; Giles, G.; Leggett, B.; Macrae, F.; Ahnen, D.; Casey, G.; Gallinger, S.; Haile, R.; Le Marchand, L.; Thibodeau, S.; Lindor, N.; Newcomb, P.; Potter, J.; et al.
2015Multi-tiered observation and response charts: prevalence and incidence of triggers, modifications and calls, to acutely deteriorating adult patientsFlabouris, A.; Nandal, S.; Vater, L.; Flabouris, K.; O'Connell, A.; Thompson, C.; Bouchama, A.
2015Recent trends in early stage response to combination antiretroviral therapy in AustraliaMcManus, H.; Hoy, J.; Woolley, I.; Boyd, M.; Kelly, M.; Mulhall, B.; Roth, N.; Petoumenos, K.; Law, M.
2015Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant Therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trialSchmoll, H.; Tabernero, J.; Maroun, J.; de Braud, F.; Price, T.; Van Cutsem, E.; Hill, M.; Hoersch, S.; Rittweger, K.; Haller, D.
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2015A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisHao, Y.; Thakkar, V.; Stevens, W.; Morrisroe, K.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.M.; Nikpour, M.